Bringing Confidence to your Prostate Cancer Treatment Decisions A revolutionary platform that delivers tailored insights for prostate cancer management,
Avenda Health, Inc. has raised $8.1M in total funding. The most recent round was Series B.
Avenda Health, Inc. is headquartered in Santa Monica, CA.
Bringing Confidence to your Prostate Cancer Treatment Decisions A revolutionary platform that delivers tailored insights for prostate cancer management,
Without precise knowledge of where prostate cancer is located, treating the whole prostate causes urinary/sexual dysfunction in over half of patients, while focal treatment can leave 24-49% of patients with residual cancer.
Avenda Health's Unfold AI platform uses a patient's MRI, biopsy, pathology, and PSA data with AI to generate a 3D Cancer Estimation Map showing exactly where the cancer is, helping guide treatment decisions.
The site cites a study claiming patients treated with Unfold AI margins are 71% more likely to be cancer-free, and states the tool significantly outperforms MRI alone at identifying cancer extent.
Avenda Health, an AI-driven prostate cancer diagnostics company, was founded as a UCLA spinout by Dr. Shyam Natarajan, Dr. Brit Berry-Pusey, and Dr. Leonard Marks.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.